Cordis, a Johnson & Johnson company, has received CE mark for its EMPIRA and EMPIRA NC RX percutaneous transluminal coronary angioplasty (PTCA) Dilatation Catheters for the treatment of coronary artery disease.
The EMPIRA systems are designed to enable interventional cardiologists to open patients’ narrowed coronary arteries during angioplasty and stenting procedures.
The EMPIRA family of PTCA dilatation catheters incorporates several design and technology changes that have the potential to improve crossability and recrossability, allowing a physician to reach even hard to treat lesions.
Both catheters utilise the next generation DURALYN Flex balloon material which is 50% more flexible than the DURALYN balloon material used in the current dilatation catheters.
A full European commercial launch of EMPIRA is planned for Q4 2011.
Cordis has also added RADIALSOURCE Transradial Access Kit to its Radial Solutions portfolio.
RADIALSOURCE transradial sheaths are designed to provide cardiologists with atraumatic and smooth access to the radial artery during diagnostic and interventional procedures.